Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine vs 5-FU with Cisplatin in Advanced Gastric Cancer
NCT02563054Phase 3Completed
- Sponsor
- Roche
- Start
- Apr 2003
- Primary completion
- Aug 2010
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of capecitabine in gastric cancer (GC), sponsored by Roche. Started Apr 2003; status: completed.
02
Drugs
capecitabine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02563054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02563054.